세포 배양 배지 시장 : 2026 년까지의 세계 예측

출판 : MarketsandMarkets(마켓츠앤드마켓츠)출판년월 : 2022년03월

타입[무혈청(CHO, BHK, 베로세포), 줄기세포, 공지 조성, 고전적, 특수], 용도[바이오 의약품(mAbs, 백신), 진단, 조직공학], 최종 사용자(제약, 생명공학)- 2026 년까지의 세계 예측

Cell Culture Media Market by Type(Serum-free (CHO, BHK, Vero Cell), Stem Cell, Chemically Defined, Classical, Specialty), Application(Biopharmaceutical (mAbs, Vaccine), Diagnostics, Tissue Engineering), End User(Pharma, Biotech) – Global Forecast to 2026

페이지수 291
도표수 355
구성 영문조사보고서
가격

리포트목차    주문/문의    납기/라이센스안내

Sample Request

The global cell culture media market is projected to USD USD 10.3 billion by 2026 from USD 4.9 billion in 2021, at a CAGR of 16.0 % between 2021 and 2026.The growth of this market is majorly driven by the growing awareness about the benefits of cell-based vaccines, increasing demand for monoclonal antibodies (mAbs), funding for cell-based research, growth in stem cell research, the launch of new cell culture media by market players, and the growing focus on personalized medicine.On the other hand, the high cost of cell biology research is restraining the growth of this market.
세계 세포 배양 배지 시장은 2021년에서 2026년 사이에 16.0%의 CAGR로 2021년 49억 달러에서 2026년 103억 달러로 예상됩니다. 이 시장의 성장은 주로 세포의 이점에 대한 인식 증가에 의해 주도됩니다. 기반 백신, 단일클론항체(mAbs)에 대한 수요 증가, 세포 기반 연구에 대한 자금 지원, 줄기 세포 연구의 성장, 시장 참여자의 새로운 세포 배양 배지 출시, 개인 맞춤형 의학에 대한 관심 증가.

“The serum-free media segmentaccounted for the highest growth rate in the cell culturemedia market, bytype, during the forecast period”
In 2020, the serum-free media segment accounted for the largest share of the market. This can be attributed to the advantages of serum-free media over other types of media, including consistent performance, increased growth & productivity, better control over physiological responsiveness, and reduced risk of contamination by serum-borne adventitious agents in cell culture.
Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Danaher Corporation (US), Sartorius AG (Germany), Corning Incorporated (US), FUJIFILM Irvine Scientific, Inc. (Japan), Lonza Group AG (Switzerland), Becton, Dickinson and Company (US), MiltenyiBiotec (Germany), HiMedia Laboratories Pvt. Ltd. (India), STEMCELL Technologies Inc. (Canada), Biologos LLC (US), Cell Applications, Inc. (US)are some of the major players operating in the cell culturemedia market.

“Asia Pacific: The fastest-growing regionin thecell culturemedia market”
Thecell culturemedia market is segmented into North America, Europe, Asia Pacific,Latin America (LATAM) and Middle East and Africa (MEA). The Asia Pacific market is expected to register the highest CAGR of 17.5% during the forecast period. The growing geriatric population, favorable regulatory guidelines, government support for cell culture-based vaccine production, low manufacturing costs, and the growing focus of global market players on emerging Asian economies are the major factors contributing to the growth of the cell culture media market in the Asia Pacific.

The primary interviews conducted for this report can be categorized as follows:

• By Respondent: Supply Side- 80%and Demand Side 20%
• By Designation: C-level – 45%, D-level – 30%, and Others – 25%
• By Region: North America -20%, Europe -10%, Asia-Pacific -55%, Latin America -10%, Middle East & Africa- 5%
List of Companies Profiled in the Report:
• Thermo Fisher Scientific Inc. (US)
• Merck KGaA (Germany)
• Danaher Corporation (US)
• Corning Incorporated (US)
• Sartorius AG (Germany)
• FUJIFILM Irvine Scientific, Inc. (Japan)
• Lonza Group AG (Switzerland)
• Becton, Dickinson and Company (US)
• MiltenyiBiotec (Germany)
• HiMedia Laboratories Pvt. Ltd. (India)
• STEMCELL Technologies Inc. (Canada)
• Biologos LLC (US)
• Cell Applications, Inc. (US)
• Caisson Laboratories Inc. (US)
• PromoCell GmbH (Germany)
• Cell Biologics, Inc. (US)
• InvivoGen (France)
• PAN-Biotech GmbH (Germany)
• PeproTech, Inc. (US)
• Cellular Technology Limited, LLC (US)
• ZenBio, Inc. (US)
• Athena Environmental Sciences, Inc. (US)
• Cyagen Biosciences (US)
• Biowest SAS (France)
• Akron Biotech (US)
Research Coverage:
This report provides a detailed picture of thecell culturemedia market. It aims at estimating the size and future growth potential of the market across different segments such as thetype, application, end user and region. The report also includes an in-depth competitive analysis ofthe key market players along with their company profiles recent developments and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall cell culture mediamarketand its subsegments.It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers,restraints, challenges,trends,and opportunities.


목차

TABLE OF CONTENTS

1 INTRODUCTION (Page No. – 39)
    1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY (Page No. – 43)
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
FIGURE 2 BREAKDOWN OF PRIMARIES: CELL CULTURE MEDIA MARKET
2.2 MARKET ESTIMATION METHODOLOGY
FIGURE 3 CELL CULTURE MEDIA MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2020
FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2020
2.2.1 INSIGHTS FROM PRIMARY EXPERTS
FIGURE 5 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
2.3 MARKET GROWTH RATE PROJECTIONS
FIGURE 6 CELL CULTURE MEDIA MARKET (SUPPLY-SIDE): CAGR PROJECTIONS
FIGURE 7 CELL CULTURE MEDIA MARKET (DEMAND-SIDE): GROWTH ANALYSIS OF DEMAND-SIDE FACTORS
2.4 DATA TRIANGULATION
FIGURE 8 DATA TRIANGULATION METHODOLOGY
2.5 RESEARCH ASSUMPTIONS
2.5.1 COVID-19-SPECIFIC ASSUMPTIONS
2.6 RISK ANALYSIS

3 EXECUTIVE SUMMARY (Page No. – 54)
FIGURE 9 CELL CULTURE MEDIA MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
FIGURE 10 CELL CULTURE MEDIA MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
FIGURE 11 CELL CULTURE MEDIA MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE CELL CULTURE MEDIA MARKET

4 PREMIUM INSIGHTS (Page No. – 58)
4.1 CELL CULTURE MEDIA MARKET OVERVIEW
FIGURE 13 RISING R&D SPENDING IN PHARMA COMPANIES AND EMERGING CELL CULTURE TECHNOLOGIES FOR CELL-BASED VACCINES WILL DRIVE MARKET GROWTH
4.2 NORTH AMERICA: CELL CULTURE MEDIA MARKET, BY TYPE AND COUNTRY (2020)
FIGURE 14 SERUM-FREE MEDIA SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN CELL CULTURE MEDIA MARKET IN 2020
4.3 CELL CULTURE MEDIA MARKET SHARE, BY APPLICATION, 2021 VS. 2026
FIGURE 15 BIOPHARMACEUTICAL PRODUCTION SEGMENT WILL CONTINUE TO DOMINATE THE MARKET IN 2026
4.4 CELL CULTURE MEDIA MARKET, BY END USER, 2020 (USD MILLION)
FIGURE 16 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT DOMINATED THE MARKET IN 2020
4.5 CELL CULTURE MEDIA MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 17 ASIA PACIFIC COUNTRIES TO REGISTER THE HIGHEST GROWTH IN THE CELL CULTURE MEDIA MARKET FROM 2021 TO 2026

5 MARKET OVERVIEW (Page No. – 62)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 18 CELL CULTURE MEDIA MARKET: DRIVERS, RESTRAINT, OPPORTUNITIES, AND CHALLENGES
TABLE 1 CELL CULTURE MEDIA MARKET: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Rising R&D spending in pharmaceutical companies
FIGURE 19 GLOBAL PHARMACEUTICAL R&D SPENDING, 2012–2026
5.2.1.2 Emerging cell culture technologies for cell-based vaccines
TABLE 2 APPROVED CELL CULTURE-BASED VACCINES FOR INFLUENZA
5.2.1.3 Increasing demand for monoclonal antibodies
TABLE 3 APPROVED MONOCLONAL ANTIBODIES BY US FDA FOR THERAPEUTIC USE
5.2.1.4 Growth in stem cell research
5.2.1.5 Launch of new cell culture media products by market players
5.2.1.6 Growing focus on personalized medicine
TABLE 4 GROWTH IN THE NUMBER OF PERSONALIZED MEDICINES
FIGURE 20 GROWING NUMBER OF FDA APPROVALS FOR PERSONALIZED MEDICINES
5.2.2 RESTRAINTS
5.2.2.1 Expensive cell biology research products
5.2.2.2 Ethical concerns regarding cell biology research
5.2.3 OPPORTUNITIES
5.2.3.1 Advancements in 3D cell culture
5.2.3.2 Increasing incidence of infectious diseases and outbreaks of pandemics
5.2.3.3 Emerging markets
5.2.4 CHALLENGES
5.2.4.1 Survival of small players and new entrants
5.3 RANGES/SCENARIOS
FIGURE 21 SPECTRUM OF SCENARIOS BASED ON THE IMPACT OF UNCERTAINTIES ON THE GROWTH OF THE CELL CULTURE MEDIA MARKET
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 22 REVENUE SHIFT & NEW REVENUE POCKETS FOR CELL CULTURE MEDIA PROVIDERS
5.5 IMPACT OF THE COVID-19 OUTBREAK ON THE CELL CULTURE MEDIA MARKET
FIGURE 23 CELL CULTURE MEDIA MARKET SCENARIO WITH AND WITHOUT COVID-19 IMPACT, 2019–2021
5.6 PRICING ANALYSIS
TABLE 5 AVERAGE SELLING PRICE OF DIFFERENT TYPES OF MEDIA/1000 L IN DEVELOPED AND DEVELOPING COUNTRIES (2020)
5.7 PATENT ANALYSIS
FIGURE 24 PATENT APPLICATIONS FOR THE CELL CULTURE MEDIA MARKET, JANUARY 2011–FEBRUARY 2022
TABLE 6 INDICATIVE LIST OF PATENTS IN THE CELL CULTURE MEDIA MARKET
5.8 VALUE CHAIN ANALYSIS
FIGURE 25 VALUE CHAIN ANALYSIS OF THE CELL CULTURE MEDIA MARKET: RAW MATERIAL AND MANUFACTURING PHASE CONTRIBUTES MAXIMUM VALUE
5.9 SUPPLY CHAIN ANALYSIS
FIGURE 26 CELL CULTURE MEDIA MARKET: SUPPLY CHAIN ANALYSIS
5.10 ECOSYSTEM ANALYSIS OF THE CELL CULTURE MEDIA MARKET
TABLE 7 SUPPLY CHAIN ECOSYSTEM
5.11 PORTER’S FIVE FORCES ANALYSIS
TABLE 8 CELL CULTURE MEDIA MARKET: PORTER’S FIVE FORCES ANALYSIS
5.11.1 THREAT OF NEW ENTRANTS
5.11.2 THREAT OF SUBSTITUTES
5.11.3 BARGAINING POWER OF SUPPLIERS
5.11.4 BARGAINING POWER OF BUYERS
5.12 REGULATORY ANALYSIS
5.12.1 US
5.12.2 EUROPE

6 CELL CULTURE MEDIA MARKET, BY TYPE (Page No. – 87)
6.1 INTRODUCTION
TABLE 9 CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
6.1.1 SERUM-FREE MEDIA
TABLE 10 SERUM-FREE MEDIA OFFERED BY KEY MARKET PLAYERS
TABLE 11 SERUM-FREE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 12 SERUM-FREE MEDIA MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 13 NORTH AMERICA: SERUM-FREE MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 14 EUROPE: SERUM-FREE MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 15 ASIA PACIFIC: SERUM-FREE MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 16 LATIN AMERICA: SERUM-FREE MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.1.1.1 CHO media
6.1.1.1.1 Growing adoption of CHO media in biopharmaceutical companies to drive the growth of this market segment
TABLE 17 CHO MEDIA OFFERED BY KEY MARKET PLAYERS
TABLE 18 CHO MEDIA MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 19 NORTH AMERICA: CHO MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 20 EUROPE: CHO MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 21 ASIA PACIFIC: CHO MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 22 LATIN AMERICA: CHO MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.1.1.2 HEK 293 media
6.1.1.2.1 Advantages of HEK 293 cell lines are expected to drive the growth of this market segment
TABLE 23 HEK 293 MEDIA OFFERED BY KEY MARKET PLAYERS
TABLE 24 HEK 293 MEDIA MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 25 NORTH AMERICA: HEK 293 MEDIA MARKET, BY COUNTRY,  2019–2026 (USD MILLION)
TABLE 26 EUROPE: HEK 293 MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 27 ASIA PACIFIC: HEK 293 MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 28 LATIN AMERICA: HEK 293 MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.1.1.3 BHK media
6.1.1.3.1 BHK media have wide applications in the production of recombinant proteins
TABLE 29 BHK MEDIA OFFERED BY KEY MARKET PLAYERS
TABLE 30 BHK MEDIA MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 31 NORTH AMERICA: BHK MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 32 EUROPE: BHK MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 33 ASIA PACIFIC: BHK MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 34 LATIN AMERICA: BHK MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.1.1.4 Vero cell media
6.1.1.4.1 Increasing role of Vero cells in research pertaining to viral vaccines to drive the growth of this market segment
TABLE 35 VERO CELL MEDIA OFFERED BY KEY MARKET PLAYERS
TABLE 36 VERO CELL MEDIA MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 37 NORTH AMERICA: VERO CELL MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 38 EUROPE: VERO CELL MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 39 ASIA PACIFIC: VERO CELL MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 40 LATIN AMERICA: VERO CELL MEDIA MARKET, BY COUNTRY,  2019–2026 (USD MILLION)
6.1.1.5 Serum-free stem cell media
6.1.1.5.1 Availability of funding for stem cell research driving the growth of this market segment
TABLE 41 SERUM-FREE STEM CELL MEDIA OFFERED BY KEY MARKET PLAYERS
TABLE 42 SERUM-FREE STEM CELL MEDIA MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 43 NORTH AMERICA: SERUM-FREE STEM CELL MEDIA MARKET,  BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 44 EUROPE: SERUM-FREE STEM CELL MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 45 ASIA PACIFIC: SERUM-FREE STEM CELL MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 46 LATIN AMERICA: SERUM-FREE STEM CELL MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.1.1.6 Insect cell media
6.1.1.6.1 Growing adoption of insect cell media for heterologous protein expression driving the growth of this market segment
TABLE 47 INSECT CELL MEDIA OFFERED BY KEY MARKET PLAYERS
TABLE 48 INSECT CELL MEDIA MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 49 NORTH AMERICA: INSECT CELL MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 50 EUROPE: INSECT CELL MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 51 ASIA PACIFIC: INSECT CELL MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 52 LATIN AMERICA: INSECT CELL MEDIA MARKET, BY COUNTRY,  2019–2026 (USD MILLION)
6.1.1.7 CAR T-cell media
6.1.1.7.1 Growing demand for adoptive T-cell therapy to drive the growth of this market segment
TABLE 53 CAR T-CELL MEDIA OFFERED BY KEY MARKET PLAYERS
TABLE 54 CAR T-CELL MEDIA MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 55 NORTH AMERICA: CAR T-CELL MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 56 EUROPE: CAR T-CELL MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 57 ASIA PACIFIC: CAR T-CELL MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 58 LATIN AMERICA: CAR T-CELL MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.1.1.8 Other serum-free media
TABLE 59 OTHER SERUM-FREE MEDIA OFFERED BY KEY MARKET PLAYERS
TABLE 60 OTHER SERUM-FREE MEDIA MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 61 NORTH AMERICA: OTHER SERUM-FREE MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 62 EUROPE: OTHER SERUM-FREE MEDIA MARKET, BY COUNTRY,  2019–2026 (USD MILLION)
TABLE 63 ASIA PACIFIC: OTHER SERUM-FREE MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 64 LATIN AMERICA: OTHER SERUM-FREE MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.1.2 CLASSICAL MEDIA & SALTS
6.1.2.1 Wide use of classical media & salts across all types of cell culture applications to drive the growth of this market segment
TABLE 65 CLASSICAL MEDIA & SALTS OFFERED BY KEY MARKET PLAYERS
TABLE 66 CLASSICAL MEDIA & SALTS MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 67 NORTH AMERICA: CLASSICAL MEDIA & SALTS MARKET, BY COUNTRY, 026 (USD MILLION)
TABLE 69 ASIA PACIFIC: CLASSICAL MEDIA & SALTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 70 LATIN AMERICA: CLASSICAL MEDIA & SALTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.1.3 STEM CELL CULTURE MEDIA
6.1.3.1 Increasing collaborations between universities and pharma-biotech companies for stem cell research to drive the growth of this market segment
TABLE 71 STEM CELL CULTURE MEDIA OFFERED BY KEY MARKET PLAYERS
TABLE 72 STEM CELL CULTURE MEDIA MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 73 NORTH AMERICA: STEM CELL CULTURE MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 74 EUROPE: STEM CELL CULTURE MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 75 ASIA PACIFIC: STEM CELL CULTURE MEDIA MARKET, BY COUNTRY,  2019–2026 (USD MILLION)
TABLE 76 LATIN AMERICA: STEM CELL CULTURE MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.1.4 CHEMICALLY DEFINED (CD) MEDIA
6.1.4.1 Ability of CD media to increase reproducibility to drive the growth of this market segment
TABLE 77 CHEMICALLY DEFINED MEDIA OFFERED BY KEY MARKET PLAYERS
TABLE 78 CHEMICALLY DEFINED MEDIA MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 79 NORTH AMERICA: CHEMICALLY DEFINED MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 80 EUROPE: CHEMICALLY DEFINED MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 81 ASIA PACIFIC: CHEMICALLY DEFINED MEDIA MARKET, BY COUNTRY,  2019–2026 (USD MILLION)
TABLE 82 LATIN AMERICA: CHEMICALLY DEFINED MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.1.5 SPECIALTY MEDIA
6.1.5.1 Ability of primary cells to proliferate in specialty media is expected to fuel the growth of this market segment
TABLE 83 SPECIALTY MEDIA OFFERED BY KEY MARKET PLAYERS
TABLE 84 SPECIALTY MEDIA MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 85 NORTH AMERICA: SPECIALTY MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 86 EUROPE: SPECIALTY MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 87 ASIA PACIFIC: SPECIALTY MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 88 LATIN AMERICA: SPECIALTY MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.1.6 OTHER CELL CULTURE MEDIA
TABLE 89 OTHER CELL CULTURE MEDIA OFFERED BY KEY MARKET PLAYERS
TABLE 90 OTHER CELL CULTURE MEDIA MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 91 NORTH AMERICA: OTHER CELL CULTURE MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 92 EUROPE: OTHER CELL CULTURE MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 93 ASIA PACIFIC: OTHER CELL CULTURE MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 94 LATIN AMERICA: OTHER CELL CULTURE MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)

7 CELL CULTURE MEDIA MARKET, BY APPLICATION (Page No. – 127)
7.1 INTRODUCTION
TABLE 95 CELL CULTURE MEDIA MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
7.2 BIOPHARMACEUTICAL PRODUCTION
TABLE 96 CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY REGION, 2019–2026 (USD MILLION)
TABLE 97 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 98 EUROPE: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 99 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 100 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 101 CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION,  BY TYPE, 2019–2026 (USD MILLION)
7.2.1 MONOCLONAL ANTIBODY PRODUCTION
7.2.1.1 Growing demand for monoclonal antibody production is fueling the growth of this market segment
TABLE 102 INDICATIVE LIST OF APPROVED ANTIBODY PRODUCTS PRODUCED IN CHO CELLS
TABLE 103 INDICATIVE LIST OF MONOCLONAL ANTIBODIES WITH FDA AUTHORIZATION
TABLE 104 CELL CULTURE MEDIA MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY REGION, 2019–2026 (USD MILLION)
TABLE 105 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 106 EUROPE: CELL CULTURE MEDIA MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 107 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 108 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.2 VACCINE PRODUCTION
7.2.2.1 Growing government support for vaccine production to drive the growth of this market segment
TABLE 109 NIH FUNDING FOR VACCINE RESEARCH, 2018–2022 (USD MILLION)
TABLE 110 CELL CULTURE MEDIA MARKET FOR VACCINE PRODUCTION, BY REGION, 2019–2026 (USD MILLION)
TABLE 111 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 112 EUROPE: CELL CULTURE MEDIA MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 113 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 114 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.3 OTHER THERAPEUTIC PROTEIN PRODUCTION
TABLE 115 CELL CULTURE MEDIA MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY REGION, 2019–2026 (USD MILLION)
TABLE 116 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 117 EUROPE: CELL CULTURE MEDIA MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 118 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 119 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION)
7.3 DIAGNOSTICS
7.3.1 INCREASING INCIDENCE OF INFECTIOUS DISEASES TO DRIVE THE GROWTH OF THIS MARKET SEGMENT
TABLE 120 CELL CULTURE MEDIA MARKET FOR DIAGNOSTICS, BY REGION, 2019–2026 (USD MILLION)
TABLE 121 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR DIAGNOSTICS, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 122 EUROPE: CELL CULTURE MEDIA MARKET FOR DIAGNOSTICS, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 123 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR DIAGNOSTICS, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 124 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR DIAGNOSTICS, BY COUNTRY, 2019–2026 (USD MILLION)
7.4 DRUG SCREENING & DEVELOPMENT
7.4.1 ADOPTION OF CELL-BASED ASSAYS IN DRUG DISCOVERY WILL DRIVE THE GROWTH OF THIS MARKET SEGMENT
TABLE 125 CELL CULTURE MEDIA MARKET FOR DRUG SCREENING & DEVELOPMENT, BY REGION, 2019–2026 (USD MILLION)
TABLE 126 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 127 EUROPE: CELL CULTURE MEDIA MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 128 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 129 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2019–2026 (USD MILLION)
7.5 TISSUE ENGINEERING & REGENERATIVE MEDICINE
TABLE 130 CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 131 CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION, 2019–2026 (USD MILLION)
TABLE 132 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 133 EUROPE: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 134 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 135 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2019–2026 (USD MILLION)
7.5.1 CELL & GENE THERAPY
7.5.1.1 Increasing adoption of cell and gene therapies for treating patients to fuel the growth of this market
TABLE 136 CELL CULTURE MEDIA MARKET FOR CELL & GENE THERAPY, BY REGION, 2019–2026 (USD MILLION)
TABLE 137 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 138 EUROPE: CELL CULTURE MEDIA MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 139 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 140 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2019–2026 (USD MILLION)
7.5.2 OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS
TABLE 141 CELL CULTURE MEDIA MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY REGION, 2019–2026 (USD MILLION)
TABLE 142 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 143 EUROPE: CELL CULTURE MEDIA MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 144 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 145 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)
7.6 OTHER APPLICATIONS
TABLE 146 CELL CULTURE MEDIA MARKET FOR OTHER APPLICATIONS, BY REGION, 2019–2026 (USD MILLION)
TABLE 147 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 148 EUROPE: CELL CULTURE MEDIA MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 149 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 150 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)

8 CELL CULTURE MEDIA MARKET, BY END USER (Page No. – 157)
8.1 INTRODUCTION
TABLE 151 CELL CULTURE MEDIA MARKET, BY END USER, 2019–2026 (USD MILLION)
8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
8.2.1 INCREASING RESEARCH EXPENDITURE BY PHARMA AND BIOTECH COMPANIES WILL DRIVE THE GROWTH OF THIS SEGMENT
TABLE 152 CELL CULTURE MEDIA MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2019–2026 (USD MILLION)
TABLE 153 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 154 EUROPE: CELL CULTURE MEDIA MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 155 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 156 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION)
8.3 HOSPITALS & DIAGNOSTIC LABORATORIES
8.3.1 INCREASING APPLICATIONS OF CELL CULTURE MEDIA IN DISEASE DIAGNOSIS TO DRIVE THE GROWTH OF THIS SEGMENT
TABLE 157 CELL CULTURE MEDIA MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2019–2026 (USD MILLION)
TABLE 158 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 159 EUROPE: CELL CULTURE MEDIA MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 160 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 161 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2019–2026 (USD MILLION)
8.4 RESEARCH & ACADEMIC INSTITUTES
8.4.1 GROWING PREVALENCE OF CANCER AND INCREASING RESEARCH FUNDING TO DRIVE THE GROWTH OF THIS SEGMENT
TABLE 162 CELL CULTURE MEDIA MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2019–2026 (USD MILLION)
TABLE 163 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 164 EUROPE: CELL CULTURE MEDIA MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 165 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 166 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2019–2026 (USD MILLION)
8.5 OTHER END USERS
TABLE 167 CELL CULTURE MEDIA MARKET FOR OTHER END USERS, BY REGION, 2019–2026 (USD MILLION)
TABLE 168 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR OTHER END USERS, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 169 EUROPE: CELL CULTURE MEDIA MARKET FOR OTHER END USERS,  BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 170 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR OTHER END USERS, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 171 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR OTHER END USERS, BY COUNTRY, 2019–2026 (USD MILLION)

9 CELL CULTURE MEDIA MARKET, BY REGION (Page No. – 170)
9.1 INTRODUCTION
TABLE 172 CELL CULTURE MEDIA MARKET, BY REGION, 2019–2026 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 27 NORTH AMERICA: CELL CULTURE MEDIA MARKET SNAPSHOT
TABLE 173 NORTH AMERICA: CELL CULTURE MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 174 NORTH AMERICA: CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 175 NORTH AMERICA: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 176 NORTH AMERICA: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 177 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
TABLE 178 NORTH AMERICA: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 179 NORTH AMERICA: CELL CULTURE MEDIA MARKET, BY END USER, 2019–2026 (USD MILLION)
9.2.1 US
9.2.1.1 Growing pharmaceutical and biotechnology sector in the US to drive market growth
TABLE 180 US: CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 181 US: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 182 US: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 183 US: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
TABLE 184 US: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 185 US: CELL CULTURE MEDIA MARKET, BY END USER, 2019–2026 (USD MILLION)
9.2.2 CANADA
9.2.2.1 Increase in stem cell research funding in Canada to fuel market growth
TABLE 186 CANADA: CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 187 CANADA: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 188 CANADA: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 189 CANADA: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
TABLE 190 CANADA: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 191 CANADA: CELL CULTURE MEDIA MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3 EUROPE
TABLE 192 EUROPE: CELL CULTURE MEDIA MARKET, BY COUNTRY,  2019–2026 (USD MILLION)
TABLE 193 EUROPE: CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 194 EUROPE: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE,  2019–2026 (USD MILLION)
TABLE 195 EUROPE: CELL CULTURE MEDIA MARKET, BY APPLICATION,  2019–2026 (USD MILLION)
TABLE 196 EUROPE: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
TABLE 197 EUROPE: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 198 EUROPE: CELL CULTURE MEDIA MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 Strong growth in the biotechnology industry in Germany to drive market growth
TABLE 199 GERMANY: CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 200 GERMANY: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 201 GERMANY: CELL CULTURE MEDIA MARKET, BY APPLICATION,  2019–2026 (USD MILLION)
TABLE 202 GERMANY: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
TABLE 203 GERMANY: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 204 GERMANY: CELL CULTURE MEDIA MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.2 UK
9.3.2.1 Advancements in the life sciences sector to boost market growth in the UK
TABLE 205 UK: CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 206 UK: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE,  2019–2026 (USD MILLION)
TABLE 207 UK: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 208 UK: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
TABLE 209 UK: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 210 UK: CELL CULTURE MEDIA MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.3 FRANCE
9.3.3.1 Increase in government funding for life science research to drive market growth in France
TABLE 211 FRANCE: CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 212 FRANCE: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 213 FRANCE: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 214 FRANCE: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
TABLE 215 FRANCE: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 216 FRANCE: CELL CULTURE MEDIA MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.4 ITALY
9.3.4.1 Growing support for life science research in Italy to fuel market growth
TABLE 217 ITALY: CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 218 ITALY: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 219 ITALY: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 220 ITALY: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
TABLE 221 ITALY: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 222 ITALY: CELL CULTURE MEDIA MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.5 SPAIN
9.3.5.1 Advancement of translational personalized medicine to aid market growth in Spain
TABLE 223 SPAIN: CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 224 SPAIN: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 225 SPAIN: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 226 SPAIN: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
TABLE 227 SPAIN: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 228 SPAIN: CELL CULTURE MEDIA MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.6 REST OF EUROPE
TABLE 229 ROE: CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 230 ROE: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 231 ROE: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 232 ROE: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
TABLE 233 ROE: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 234 ROE: CELL CULTURE MEDIA MARKET, BY END USER 2019–2026 (USD MILLION)
9.4 ASIA PACIFIC
FIGURE 28 ASIA PACIFIC: CELL CULTURE MEDIA MARKET SNAPSHOT
TABLE 235 ASIA PACIFIC: CELL CULTURE MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 236 ASIA PACIFIC: CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 237 ASIA PACIFIC: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 238 ASIA PACIFIC: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 239 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
TABLE 240 ASIA PACIFIC: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 241 ASIA PACIFIC: CELL CULTURE MEDIA MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4.1 CHINA
9.4.1.1 China to register the highest growth rate in the Asia Pacific cell culture media market during the forecast period
TABLE 242 CHINA: CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 243 CHINA: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 244 CHINA: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 245 CHINA: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
TABLE 246 CHINA: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 247 CHINA: CELL CULTURE MEDIA MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4.2 JAPAN
9.4.2.1 Increasing geriatric population along with rising cancer cases to drive market growth in Japan
TABLE 248 JAPAN: CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 249 JAPAN: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 250 JAPAN: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 251 JAPAN: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
TABLE 252 JAPAN: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 253 JAPAN: CELL CULTURE MEDIA MARKET, BY END USER,  2019–2026 (USD MILLION)
9.4.3 INDIA
9.4.3.1 Government support for scientific research and expansion of the pharma-biotech sector to drive market growth in India
TABLE 254 INDIA: CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 255 INDIA: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 256 INDIA: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 257 INDIA: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
TABLE 258 INDIA: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 259 INDIA: CELL CULTURE MEDIA MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4.4 REST OF ASIA PACIFIC
TABLE 260 ROAPAC: CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 261 ROAPAC: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 262 ROAPAC: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 263 ROAPAC: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
TABLE 264 ROAPAC: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 265 ROAPAC: CELL CULTURE MEDIA MARKET, BY END USER, 2019–2026 (USD MILLION)
9.5 LATIN AMERICA
TABLE 266 LATIN AMERICA: CELL CULTURE MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 267 LATIN AMERICA: CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 268 LATIN AMERICA: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 269 LATIN AMERICA: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 270 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
TABLE 271 LATIN AMERICA: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 272 LATIN AMERICA: CELL CULTURE MEDIA MARKET, BY END USER, 2019–2026 (USD MILLION)
9.5.1 BRAZIL
9.5.1.1 Expanding pharmaceutical market in Brazil to fuel market growth
TABLE 273 BRAZIL: CELL CULTURE MEDIA MARKET, BY TYPE,  2019–2026 (USD MILLION)
TABLE 274 BRAZIL: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE,  2019–2026 (USD MILLION)
TABLE 275 BRAZIL: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 276 BRAZIL: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
TABLE 277 BRAZIL: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 278 BRAZIL: CELL CULTURE MEDIA MARKET, BY END USER, 2019–2026 (USD MILLION)
9.5.2 MEXICO
9.5.2.1 Growth in pharmaceutical R&D and manufacturing to drive the demand for cell culture media in Mexico
TABLE 279 MEXICO: CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 280 MEXICO: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 281 MEXICO: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 282 MEXICO: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
TABLE 283 MEXICO: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 284 MEXICO: CELL CULTURE MEDIA MARKET, BY END USER, 2019–2026 (USD MILLION)
9.5.3 REST OF LATIN AMERICA
TABLE 285 ROLATAM: CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 286 ROLATAM: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 287 ROLATAM: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 288 ROLATAM: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
TABLE 289 ROLATAM: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 290 ROLATAM: CELL CULTURE MEDIA MARKET, BY END USER, 2019–2026 (USD MILLION)
9.6 MIDDLE EAST AND AFRICA
9.6.1 GROWING FUNDING INITIATIVES AND STRATEGIC PARTNERSHIPS DRIVING MARKET GROWTH IN MEA
TABLE 291 MEA: CELL CULTURE MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 292 MEA: SERUM-FREE CELL CULTURE MEDIA MARKET, BY TYPE,  2019–2026 (USD MILLION)
TABLE 293 MEA: CELL CULTURE MEDIA MARKET, BY APPLICATION,  2019–2026 (USD MILLION)
TABLE 294 MEA: CELL CULTURE MEDIA MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION)
TABLE 295 MEA: CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 296 MEA: CELL CULTURE MEDIA MARKET, BY END USER, 2019–2026 (USD MILLION)

10 COMPETITIVE LANDSCAPE (Page No. – 234)
10.1 OVERVIEW
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
FIGURE 29 KEY DEVELOPMENTS IN THE CELL CULTURE MEDIA MARKET, 2019–2022
10.3 MARKET SHARE ANALYSIS
FIGURE 30 CELL CULTURE MEDIA MARKET: MARKET SHARE ANALYSIS, BY KEY PLAYER, 2020
TABLE 297 CELL CULTURE MEDIA MARKET: DEGREE OF COMPETITION
10.4 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS
FIGURE 31 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN THE CELL CULTURE MEDIA MARKET, 2018–2020
10.5 COMPANY EVALUATION QUADRANT
10.5.1 STARS
10.5.2 EMERGING LEADERS
10.5.3 PERVASIVE PLAYERS
10.5.4 PARTICIPANTS
FIGURE 32 CELL CULTURE MEDIA MARKET: COMPANY EVALUATION QUADRANT, 2020
10.6 COMPANY EVALUATION QUADRANT: START-UPS/SMES
10.6.1 PROGRESSIVE COMPANIES
10.6.2 STARTING BLOCKS
10.6.3 RESPONSIVE COMPANIES
10.6.4 DYNAMIC COMPANIES
FIGURE 33 CELL CULTURE MEDIA MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS/SMES, 2020
10.7 PRODUCT FOOTPRINT OF COMPANIES
TABLE 298 PRODUCT PORTFOLIO ANALYSIS: CELL CULTURE MEDIA MARKET (2020)
10.8 REGIONAL FOOTPRINT OF COMPANIES
TABLE 299 REGIONAL FOOTPRINT OF COMPANIES: CELL CULTURE MEDIA MARKET (2020)
10.9 COMPETITIVE SCENARIO
TABLE 300 PRODUCT LAUNCHES
TABLE 301 DEALS
TABLE 302 EXPANSIONS

11 COMPANY PROFILES (Page No. – 247)
11.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1.1 THERMO FISHER SCIENTIFIC, INC.
TABLE 303 THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW
FIGURE 34 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2020)
11.1.2 MERCK KGAA
TABLE 304 MERCK KGAA: BUSINESS OVERVIEW
FIGURE 35 MERCK KGAA: COMPANY SNAPSHOT (2020)
11.1.3 DANAHER CORPORATION
TABLE 305 DANAHER CORPORATION: BUSINESS OVERVIEW
FIGURE 36 DANAHER CORPORATION: COMPANY SNAPSHOT (2020)
11.1.4 SARTORIUS AG
TABLE 306 SARTORIUS AG: BUSINESS OVERVIEW
FIGURE 37 SARTORIUS AG: COMPANY SNAPSHOT (2020)
11.1.5 CORNING INCORPORATED
TABLE 307 CORNING INCORPORATED: BUSINESS OVERVIEW
FIGURE 38 CORNING INCORPORATED: COMPANY SNAPSHOT (2020)
11.1.6 FUJIFILM IRVINE SCIENTIFIC, INC. (ACQUIRED BY FUJIFILM HOLDINGS CORPORATION)
TABLE 308 FUJIFILM HOLDINGS CORPORATION: BUSINESS OVERVIEW
FIGURE 39 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT (2020)
11.1.7 LONZA GROUP AG
TABLE 309 LONZA GROUP AG: BUSINESS OVERVIEW
FIGURE 40 LONZA GROUP AG: COMPANY SNAPSHOT (2020)
11.1.8 BECTON, DICKINSON AND COMPANY (BD)
TABLE 310 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
FIGURE 41 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2020)
11.1.9 MILTENYI BIOTEC
TABLE 311 MILTENYI BIOTEC: BUSINESS OVERVIEW
11.1.10 HIMEDIA LABORATORIES PVT. LTD.
TABLE 312 HIMEDIA LABORATORIES PVT. LTD.: BUSINESS OVERVIEW
11.1.11 STEMCELL TECHNOLOGIES INC.
TABLE 313 STEMCELL TECHNOLOGIES INC.: BUSINESS OVERVIEW
11.1.12 BIOLOGOS LLC.
TABLE 314 BIOLOGOS LLC.: BUSINESS OVERVIEW
11.2 OTHER PLAYERS
11.2.1 CELL APPLICATIONS, INC.
11.2.2 CAISSON LABORATORIES INC.
11.2.3 PROMOCELL GMBH
11.2.4 CELL BIOLOGICS, INC.
11.2.5 INVIVOGEN
11.2.6 PAN-BIOTECH GMBH
11.2.7 PEPROTECH, INC.
11.2.8 CELLULAR TECHNOLOGY LIMITED LLC.
11.2.9 ZEN-BIO, INC.
11.2.10 ATHENA ENVIRONMENTAL SCIENCES, INC.
11.2.11 CYAGEN BIOSCIENCES
11.2.12 BIOWEST SAS
11.2.13 AKRON BIOTECH

*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

12 APPENDIX (Page No. – 297)
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 AVAILABLE CUSTOMIZATIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS


    주문/문의폼

    • 리포트 제목은 자동으로 입력됩니다.
    • *항목은 필수항목입니다.
    • 무료샘플은 구입 검토용으로만 의뢰해 주시길 부탁드립니다. 

    의뢰분류*

    성함*

    회사명*

    부서명

    이메일*

    전화번호

    저희 사이트를 알게 된 경로를 가르쳐 주세요.

    문의 내용*

     

    ※개인정보보호정책은여기에서 확인 가능합니다。

    Email 문의도 받고 있습니다.
    아래 주소이며 죄송하지만 "(at)"을 "@"로 바꾸어 보내주시길 부탁드립니다.
    mooneui(at)chosareport-korea.com